Neural Correlates (EEG and fMRI) of Gait in Small Vessel Disease
doesn't exist
Investigating Neural Correlates of Gait Abnormalities in Patients With Cerebral Small Vessel Disease
1 other identifier
observational
40
1 country
1
Brief Summary
What is the purpose of this study? This observational study is being done to understand how cerebral small vessel disease (SVD) affects walking and balance. SVD is a common brain condition in older adults that damages small blood vessels. It can lead to problems with movement, thinking, and memory. The researchers want to find out how changes in brain activity and connectivity contribute to walking difficulties in people with SVD. Why is this study important? Walking and balance problems increase the risk of falls and loss of independence. By studying brain activity during walking-related tasks, researchers hope to identify patterns that explain why these problems happen. This knowledge could help develop better rehabilitation methods in the future. Who can participate? Adults over 50 years old with cerebral small vessel disease and gradual gait problems may be eligible. Healthy adults of similar age without neurological problems may also take part as control participants. What will happen in this study? Participants will: Complete walking, balance, and cognitive tests such as the Timed Up and Go, Berg Balance Scale, and Montreal Cognitive Assessment. Undergo brain imaging (MRI) to confirm the diagnosis and study brain structure and function. Have an EEG recording while resting and while watching short videos showing walking and turning movements. A smaller group will also undergo functional MRI (fMRI) while watching the same videos. The MRI and EEG results will be analyzed to see how brain networks involved in movement and balance differ between patients and healthy adults. How long will the study take? The study will take about two years to complete. Each participant's visit will last approximately two to three hours in total. What are the possible benefits? There may be no direct benefit to participants. However, this study may help researchers understand how small vessel disease affects brain function related to walking, which may improve care for future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2026
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
February 3, 2026
January 1, 2026
8 months
January 20, 2026
January 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional brain connectivity differences between SVD patients and healthy controls
Differences in resting-state and task-based EEG connectivity and fMRI network activation between patients with cerebral small vessel disease and healthy controls. Connectivity will be analyzed using coherence, phase-locking value (PLV), and correlation matrices derived from resting-state fMRI and EEG. The goal is to identify altered cortico-subcortical communication associated with gait impairment.
At baseline (single assessment visit)
Secondary Outcomes (1)
Correlation between imaging findings and clinical gait performance
At baseline (single assessment visit)
Study Arms (2)
Healthy Controls
Age matched adults with no neurological disorders or gait impairments and normal MRI findings. Participants will undergo the same clinical, EEG, and MRI assessments as the patient group.
SVD Patients
dults aged 50 years or older diagnosed with cerebral small vessel disease (SVD) showing gait disturbance confirmed by MRI (Fazekas score 2-3). Participants will undergo clinical assessment, EEG, and functional MRI.
Interventions
Eligibility Criteria
Adults aged 50 years or older attending the Neurology outpatient clinics at Ain Shams University Hospitals, including patients with small vessel disease and gait impairment, and healthy controls.
You may qualify if:
- Age 50 years or older.
- Clinical and radiological diagnosis of cerebral small vessel disease (SVD), confirmed by MRI findings such as white matter hyperintensities, lacunes, or microbleeds.
- Fazekas score 2 or 3 on MRI.
- Presence of slowly progressive gait disturbance (e.g., slowness, imbalance, freezing) rather than acute stroke presentation.
- Ability to give informed consent and cooperate with testing procedures.
You may not qualify if:
- Presence of other neurodegenerative disorders (e.g., Parkinson's disease, Alzheimer's disease).
- History of large vessel stroke or intracerebral hemorrhage.
- Contraindications to MRI (e.g., pacemaker, metallic implants, severe claustrophobia).
- Severe cognitive impairment that prevents participation (MoCA \<10).
- Musculoskeletal or orthopedic causes of gait disturbance not related to neurological dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University Hospitals
Cairo, Cairo Governorate, 11566, Egypt
Related Publications (5)
Torres-Simon L, Doval S, Nebreda A, Llinas SJ, Marsh EB, Maestu F. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review. Neuroimage Clin. 2022;35:103040. doi: 10.1016/j.nicl.2022.103040. Epub 2022 May 10.
PMID: 35653914RESULTSu C, Yang X, Wei S, Zhao R. Association of cerebral small vessel disease with gait and balance disorders. Front Aging Neurosci. 2022;14:834496. PMID: 35528672
RESULTMele G, Cavaliere C, Alfano V, Orsini M, Salvatore M, Aiello M. Simultaneous EEG-fMRI for Functional Neurological Assessment. Front Neurol. 2019 Aug 13;10:848. doi: 10.3389/fneur.2019.00848. eCollection 2019.
PMID: 31456735RESULTSchulz M, Malherbe C, Cheng B, Thomalla G, Schlemm E. Functional connectivity changes in cerebral small vessel disease - a systematic review of the resting-state MRI literature. BMC Medicine. 2021;19(1):234. PMID: 34521428
RESULTSharma B, Wang M, McCreary CR, Camicioli R, Smith EE. Gait and falls in cerebral small vessel disease: a systematic review and meta-analysis. Age Ageing. 2023 Mar 1;52(3):afad011. doi: 10.1093/ageing/afad011.
PMID: 37000039RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of neurology, MD candidate , Ain Shams University
Study Record Dates
First Submitted
January 20, 2026
First Posted
January 28, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01